David Heller, corporate counsel, regulatory affairs, discusses the latest regulatory news out of Washington, D.C. affecting your practice. We discuss the latest on the opioid bill signed into law by President Donald Trump recently, plus what should practices be on the look out for as we head toward the end of 2018, and into 2019.